Cargando…
Lung cancer in patients with fibrosing interstitial lung diseases: an overview of current knowledge and challenges
Patients with progressive fibrosing interstitial lung diseases (fILD) have increased morbidity and mortality. Lung fibrosis can be associated with lung cancer. The pathogenesis of both diseases shows similarities, although not all mechanisms are understood. The combination of the diseases is challen...
Autores principales: | Kewalramani, Namrata, Machahua, Carlos, Poletti, Venerino, Cadranel, Jacques, Wells, Athol U., Funke-Chambour, Manuela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209850/ https://www.ncbi.nlm.nih.gov/pubmed/35747227 http://dx.doi.org/10.1183/23120541.00115-2022 |
Ejemplares similares
-
Reply to: Pharmacotherapy for lung cancer with comorbid interstitial pneumonia: limited evidence requires appropriate evaluation
por: Funke-Chambour, Manuela, et al.
Publicado: (2022) -
Reply to comment on “The natural history of progressive fibrosing interstitial lung diseases”
por: Brown, Kevin K., et al.
Publicado: (2020) -
The natural history of progressive fibrosing interstitial lung diseases
por: Brown, Kevin K., et al.
Publicado: (2020) -
Surgical Lung Biopsy and Cryobiopsy in Fibrosing Interstitial Lung Diseases: One Swallow Does Not Make a Summer
por: Bendstrup, Elisabeth, et al.
Publicado: (2019) -
Dehydroepiandrosterone in fibrotic interstitial lung disease: a translational study
por: Guler, Sabina A., et al.
Publicado: (2022)